How the da Vinci SP system is changing selected breast cancer surgery workflows
MedStar Georgetown combines four breast procedures through one 4-centimeter robotic incision. Examine safety, sensation and clinical evidence.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
An implant for severe asthma? Spiro Medical begins testing spinal nerve stimulation beyond drugs
Spiro Medical implants its first PULSAR asthma patient as a 30-person study tests spinal nerve stimulation for severe, uncontrolled asthma.
Medical Devices & Diagnostics
Vinci Pharmaceuticals wants to replace repeated eye injections with an implant. Can $8m bring EPIPLANT into the clinic?
Vinci Pharmaceuticals secures over $8 million to advance EPIPLANT retinal drug delivery toward human trials in 2027. See what comes next.
Medical Devices & Diagnostics
Fujifilm’s new pathology AI can classify tissue changes, but is it ready for cancer diagnosis?
Fujifilm launches Synapse Pathology v3.0 with 50-plus upgrades, AI integration and a research-only foundation model for tissue analysis.
Medical Devices & Diagnostics
Can Insulet’s new diabetes data platform improve time in range and patient engagement?
Insulet launches Omnipod Discover across the US after 15,000 users adopt the platform. Examine its glucose data, clinical evidence and impact.
Medical Devices & Diagnostics
Can Teleflex’s Freesolve scaffold challenge permanent drug-eluting stents?
Teleflex completes BIOMAG-LL enrollment in 102 patients, testing longer Freesolve magnesium scaffolds ahead of European regulatory expansion.
Medical Devices & Diagnostics
Why Thermedical’s Durablate catheter could address difficult-to-reach heart arrhythmias
Thermedical names nine experts to oversee pivotal SERF ablation testing after promising early results. Safety and six-month recurrence remain key tests.
Medical Devices & Diagnostics
Can SurGenTec’s Vantage system reduce surgical instrumentation and sterilisation requirements?
SurGenTec licenses FDA-cleared Vantage from Allevion Medical, expanding disposable spinal decompression options. Examine its clinical and commercial potential.
Medical Devices & Diagnostics
AnX Robotica highlights 133-patient ARTIC study supporting ProScan AI performance
AnX Robotica reports 88.6% faster ProScan AI capsule reviews. Examine FDA evidence, diagnostic performance and why comparisons need caution.
Medical Devices & Diagnostics
Bayer’s experimental PET scan detected 94% of cardiac amyloidosis cases. Can it identify the disease earlier?
Bayer's amyloidosis PET tracer showed 94% sensitivity in Phase III. New HFSA analyses examine earlier diagnosis and finerenone treatment gaps.